Similarly, it was previously reported that BOP1 expression is related to shorter survival period in patients with prostate carcinoma [9], triple-negative breast cancer [21], gastric cancer [8], and hepatocellular carcinoma [24], and BOP1 promotes the development of these cancers. Here, BOP1 is linked to gastric cancer.